Trinity Biotech (TRIB) Gross Margin (2009 - 2024)
Trinity Biotech's (TRIB) quarterly Gross Margin came in at 30.76% in Q4 2024, down 325.0% year-on-year from 13.67% in Q1 2024, and down 12.2% quarter-over-quarter from 35.03% in Q3 2024.
Trinity Biotech (TRIB) Gross Margin (2009 - 2024) Analysis & Trends
Trinity Biotech has disclosed Gross Margin across 16 years of filings, most recently posting 30.76% for Q4 2024.
- Gross Margin for Q4 2024 came in at 30.76%, down 325.0% year-over-year; the trailing twelve-month figure through Dec 2024 was 34.83% (up 61.0% YoY), and the FY2025 annual result was 38.57%, up 374.0% from the prior year.
- Gross Margin came in at 30.76% for Q4 2024 at Trinity Biotech, down from 35.03% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 52.4% in Q3 2020 to a low of 2.1% in Q3 2022.
- The 5-year median for Gross Margin is 37.31% (2021), against an average of 36.84%.
- Across the five-year window, Gross Margin slumped 3835 bps in 2022 and jumped 2707 bps in 2023, its largest moves.
- Trinity Biotech's Gross Margin stood at 47.79% in 2020, then slipped by 22 bps to 37.08% in 2021, then retreated by 8 bps to 34.18% in 2022, then retreated by 0 bps to 34.01% in 2023, then declined by 10 bps to 30.76% in 2024.
- The last three Gross Margin figures came in at 30.76% (Q4 2024), 35.03% (Q3 2024), and 36.19% (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 43.89% |
| 10 | Trinity Biotech | 23,520.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 30.76% |
| Sep 30, 2024 | 35.03% |
| Jun 30, 2024 | 36.19% |
| Mar 31, 2024 | 37.55% |
| Dec 31, 2023 | 34.01% |
| Sep 30, 2023 | 29.16% |
| Jun 30, 2023 | 36.19% |
| Mar 31, 2023 | 37.58% |
| Dec 31, 2022 | 34.18% |
| Sep 30, 2022 | 2.10% |
| Jun 30, 2022 | 36.20% |
| Mar 31, 2022 | 38.16% |
| Dec 31, 2021 | 37.08% |
| Sep 30, 2021 | 40.45% |
| Jun 30, 2021 | 42.67% |
| Mar 31, 2021 | 42.64% |
| Dec 31, 2020 | 47.79% |
| Sep 30, 2020 | 52.40% |
| Jun 30, 2020 | 42.88% |
| Mar 31, 2020 | 43.80% |